{"transactions":[{"id":2696658,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":2.96,"exercise_date":"2021-01-06","expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696657,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":6.11,"exercise_date":"2016-06-30","expiration_date":"2026-06-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696656,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.66,"exercise_date":"2016-04-27","expiration_date":"2026-04-27","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696655,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":4.9,"exercise_date":"2016-03-31","expiration_date":"2026-03-31","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696654,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.57,"exercise_date":"2015-12-31","expiration_date":"2025-12-31","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696653,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":5.64,"exercise_date":"2015-12-31","expiration_date":"2025-09-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696652,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":0.92,"exercise_date":"2015-04-02","expiration_date":"2025-04-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696651,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.2,"exercise_date":"2015-05-07","expiration_date":"2024-05-07","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696650,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":145000,"price":11.6985,"value":1696282.5,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696649,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":50000,"price":2.96,"value":148000.0,"ownership":{"direct":true},"balance_after":145000,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696648,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":1500,"price":6.11,"value":9165.0,"ownership":{"direct":true},"balance_after":95000,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696647,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":1500,"price":5.66,"value":8490.0,"ownership":{"direct":true},"balance_after":93500,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696646,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":1500,"price":4.9,"value":7350.0,"ownership":{"direct":true},"balance_after":92000,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696645,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":1500,"price":5.57,"value":8355.0,"ownership":{"direct":true},"balance_after":90500,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696644,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":1500,"price":5.64,"value":8460.0,"ownership":{"direct":true},"balance_after":89000,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696643,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":50000,"price":0.92,"value":46000.0,"ownership":{"direct":true},"balance_after":87500,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2696642,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-26T01:30:48.000Z","date":"2021-05-21","kind":"exercise","acquired":true,"shares":37500,"price":1.2,"value":45000.0,"ownership":{"direct":true},"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001731122-21-000941","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000941/ownership.xml","form_type":"4"}},{"id":2829235,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-27T02:31:59.000Z","date":"2021-02-24","kind":"exercise","acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":3.28,"exercise_date":"2016-09-22","expiration_date":"2026-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001731122-21-000308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000308/ownership.xml","form_type":"4"}},{"id":2829234,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-27T02:31:59.000Z","date":"2021-02-24","kind":"exercise","acquired":false,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vested upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials."}],"balance_after":0,"derivative":{"exercise_price":2.58,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001731122-21-000308","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000308/ownership.xml","form_type":"4"}},{"id":2829233,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-27T02:31:59.000Z","date":"2021-02-24","kind":"sale","acquired":false,"shares":145500,"price":12.6588,"value":1841855.4,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001731122-21-000308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000308/ownership.xml","form_type":"4"}},{"id":2829232,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-27T02:31:59.000Z","date":"2021-02-24","kind":"exercise","acquired":true,"shares":100000,"price":3.28,"value":328000.0,"ownership":{"direct":true},"balance_after":145000,"source":{"system":"sec-edgar","filing":"0001731122-21-000308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000308/ownership.xml","form_type":"4"}},{"id":2829231,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-27T02:31:59.000Z","date":"2021-02-24","kind":"exercise","acquired":true,"shares":45500,"price":2.58,"value":117390.0,"ownership":{"direct":true},"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001731122-21-000308","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000308/ownership.xml","form_type":"4"}},{"id":2925164,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T19:22:39.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":5.49,"exercise_date":"2021-12-30","expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001731122-21-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000008/ownership.xml","form_type":"4"}},{"id":3315105,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T23:00:17.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.96,"exercise_date":"2021-01-06","expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-20-000020","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112220000020/ownership.xml","form_type":"4"}},{"id":3798143,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-03T21:33:47.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials."}],"balance_after":45500,"derivative":{"exercise_price":2.58,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001615774-18-010447","document":"s113108_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577418010447/s113108_form4.xml","form_type":"4"}},{"id":4594971,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":139057,"kind":"person","name":"FAVUS ELLIOT","position":1,"cik":"0001608022","reported_name":"FAVUS ELLIOT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-26T21:24:20.000Z","date":"2016-09-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":3.28,"exercise_date":"2016-09-22","expiration_date":"2026-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001615774-16-007390","document":"s104219_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577416007390/s104219_form4.xml","form_type":"4"}}]}